Apotex Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
| Apotex Inc. |
| Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG |
| 1:2024cv00577 |
| May 13, 2024 |
| US District Court for the District of Delaware |
| Patent |
| 35 U.S.C. ยง 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 14, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED re #1 MOTION to File Under Seal (Complaint and Exhibits E & M). ORDERED by Judge Maryellen Noreika on 5/14/2024. (dlw)
|
| Remark: Case submitted for routine judicial assignment. (mrr) |
| Filing 8 Summons Issued as to Boehringer Ingelheim International GmbH on 5/13/2024; Boehringer Ingelheim Pharma GmbH & Co. KG on 5/13/2024; Boehringer Ingelheim Pharmaceuticals, Inc. on 5/13/2024. (Attachments: #1 Summons Issued, #2 Summons Issued)(mrr) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdco Inc. for Apotex Inc. filed by Apotex Inc. (mrr) |
| Filing 6 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,756; 10,105,323. (mrr) |
| Filing 5 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/15/2024. Date of Expiration of Patent: U.S. Patent No. 9,907,756 expires on 06/07/2029, U.S. Patent No. 10,105,323 expires on 06/04/2029, Thirty Month Stay Deadline - Not applicable. (mrr) |
| Filing 4 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) |
| Filing 3 EXHIBITS re: #2 Complaint, by Apotex Inc. (Attachments: #1 Exhibit B, #2 Exhibit C, #3 Exhibit D, #4 Exhibit F, #5 Exhibit G, #6 Exhibit H, #7 Exhibit I, #8 Exhibit J, #9 Exhibit K, #10 Exhibit L, #11 Exhibit N, #12 Exhibit O, #13 Exhibit P, #14 Exhibit Q, #15 Exhibit R, #16 Exhibit S, #17 Exhibit T, #18 Civil Cover Sheet)(mrr) |
| Filing 2 [SEALED] COMPLAINT filed for Declaratory Judgment of Patent Non-Infringement against Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4405910.) - filed by Apotex Inc. (Attachments: #1 Exhibit E, #2 Exhibit M)(mrr) |
| Filing 1 MOTION for Leave to file Complaint and Exhibits Under Seal - filed by Apotex Inc. (Attachments: #1 Exhibit A, #2 Proposed Order)(mrr) |
| Remark: Exit electronic copies to Judge, MN. (mrr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
